Archive | June, 2013

Strong Bond Auction Punctuates 3 Day Rally in Stocks

Bond Market Stabilizes A strong bond auction today for the 7 Year Treasury at an interest rate of 1.94% helped support the three day rally easing investor concerns about rising interest rates and liquidation of bonds. European and Japanese stocks were also up. Bond mavens Jeffrey Gundlach of DoubleLine and Pimco’s Bill Gross also chimed in, […]

Continue Reading 0

Nice Recovery Day Despite Lackluster Tape-Healthcare Lagging Sector

Global Economic Picture Not Good-Healthcare A Laggard on Rally Day Strong housing and durable goods data supported the rally today taking the S&P up 0.95% and NASDAQ up 0.82%. Comments from the China’s Central Bank helped a recovery from a free fall in the FXI at $31.70 down from the $41 level earlier this year. The […]

Continue Reading 0

Biotech Bull Market Intact But Speculation Is In Check Update 1

Life Science Stocks in Corrective Mode-Look for Support Today   Update-winners could not hold tops with IBB ending day at $167, NASDAQ at 3321 The sector sell-off which began off the May top (up 30%) and picked up downward momentum in June is continuing today. However some large cap quality stocks in the Rayno Portfolio […]

Continue Reading 0

Rayno Life Science Portfolios With Sector Up 20% YTD 6/20/13

Rayno Diagnostics and Tools Portfolio    Prices as of 5/29/13 Top 2013 Winners: ABAX, ALR, CSII, GHDX, ILMN, TMO, VRML Sector high was in mid-May Less volatile than biopharma but more dependent on earnings Five companies on focus list were acquired over 3 years 2010-2013 Original Price Price % Price Price % RET Price %RET […]

Continue Reading 0

FED No Change: Market Down 1% as Less Monetary Accommodation Likely in Future

Downside Risk to Economy Diminished So Less “Extreme Monetary Policy” In the Future? Market Stable with downward bias :S&P flat to down 18 pts-10 Year Bond Yield At 2.28% up 3.9% FED Is Optimistic  about the economy: housing, consumer sentiment, financial backdrop but with fiscal drag. Bond purchases are tied to the economy. The FED […]

Continue Reading 0

Biotech Bull Market Momentum is Easing So Watch High Flyers: AEGR,CLVS etc- Update 6/16

Biotech Sell-Off Continues Nothing dramatic but the overall weakness in biopharmaceutical stocks is continuing today despite a strong performance by NASDAQ up 1.2% at 3464. With biotech having one of it best years of all time, profit taking is expected. The most popular ETFs IBB down 0.4% and XBI down 0.4% are weak but are […]

Continue Reading 0

Rayno Diagnostics and Tools Update: MYGN, SQNM Update 2 June 14

6/14  Supreme Court Ruling on Genetic Tests Takes Down Myriad Stock (MYGN $30.50)-Off Another 3% but still up 13% YTD. The Supreme Court ruling opens up competition for Myriad’s breast cancer tests as well as other genetic disease markers.The immediate reaction to the stock was initially positive yesterday but abruptly turned negative after stock downgrades […]

Continue Reading 0

Choppy Market with Macro in Forefront: Currency, Turkey, iRates

Life Science Stocks Holding Up Amidst Volatility-Stay Cautious Biotech stocks are mixed today as volatility from currency moves and violence in Turkey and the Middle East gives pause to investors. Bonds have corrected almost 5% prompting an exit from bond funds as the 10 Year Treasury hits the 2.19 % (high as 2.30) level up […]

Continue Reading 0

Jobs Data Triggers 1% Rally; Life Science Sector Up 2%

Risk On With Jobs Data in Sweet Spot Life Science Stocks Rally 2+ % Stocks rose over 1% after analysts felt jobs report was “not too hot nor not too cold” extending sentiment for an accommodative FED.  The rally is holding before the close as investors feel bullish after a volatile week.Some analysts are forecasting […]

Continue Reading 0

ASCO Day 3: News and Daily Movers in Risk-Off Mode CELG,GILD,IBB,PCYC

Market Correction Is Here-IBB at 170 off 2%+ The biotech sector sell-off (IBB at $170) continues today despite an effort to rally in the opening (IBB at $178). The biotech sector now tracks  the overall market and is no longer immune to macro issues and economic events. Market concerns this week are the volatility and […]

Continue Reading 0